Mangoceuticals Inc.

NASDAQ: MGRX · Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 3:59 PM
1.55
-4.62%
After-hours: Aug 15, 2025, 04:03 PM EDT

Mangoceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
58.65K 739.01K 682.86K 22.55K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 16.94K 16.94K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a 18.5K n/a n/a
Other Current Assets
16.94K n/a n/a n/a
Total Current Assets
75.59K 818.46K 694.61K 22.55K
Property-Plant & Equipment
62.3K 215.39K 291.74K n/a
Goodwill & Intangibles
15.23M n/a n/a n/a
Total Long-Term Assets
15.29M 232.33K 308.68K n/a
Total Assets
15.37M 1.05M 1M 22.55K
Account Payables
837.5K 140.76K 33.67K n/a
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
150K n/a 167.46K 39.27K
Other Current Liabilities
373K n/a n/a n/a
Total Current Liabilities
1.43M 211.08K 260.58K 39.27K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 64.96K 128.68K n/a
Total Liabilities
1.43M 276.04K 389.26K 39.27K
Total Debt
214.96K 128.68K 352.87K 39.27K
Common Stock
325.00 2.14K 1.34K 800.00
Retained Earnings
-20.81M -11.23M -2.02M -17.7K
Comprehensive Income
-9.85K n/a n/a n/a
Shareholders Equity
13.95M 774.75K 614.03K -16.72K
Total Investments
n/a n/a n/a n/a